Bone mass and microarchitecture of irradiated and bone marrow-transplanted mice: influences of the donor strain

SummaryTotal body irradiation and bone marrow transplantation induced dramatic trabecular bone loss and cortical thickening in mice. Transplanted cells were engrafted in bone marrow, along trabeculae, and in periosteal and endosteal envelopes. None of the osteocytes were of donor origin. Bone microarchitecture of transplanted mice changed to tend toward the donor phenotype.IntroductionOsteopenia and osteoporosis are complications of bone marrow transplants (BMT) attributed to related chemotherapy. However, the specific influence of total body irradiation (TBI) is unknown.MethodsWe investigated the effects of TBI and BMT on bone mass and microarchitecture by micro-CT. Eighteen C57Bl/6 (B6) mice receiving lethal TBI had a BMT with marrow cells from green fluorescent protein--transgenic-C57Bl/6 (GFP) mice. Transplanted (TGFPB6), B6, and GFP mice were euthanized 1, 3, and 6 months after BMT or at a related age.ResultsTGFPB6 presented a dramatic bone loss compared with B6 and did not restore their trabecular bone mass over time, despite a cortical thickening 6 months after BMT. Serum testosterone levels were not significantly reduced after BMT. During aging, GFP mice have less trabeculae, thicker cortices, but a narrower femoral shaft than B6 mice. From 3 months after BMT, cortical characteristics of TGFPB6 mice differed statistically from B6 mice and were identical to those of GFP mice. GFP+ cells were located along trabecular surfaces and in periosteal and endosteal envelopes, but none of the osteocytes expressed GFP.ConclusionOur findings suggest that engrafted cells did not restore the irradiation-induced trabecular bone loss, but reconstituted a marrow microenvironment and bone remodeling similar to those of the donor. The effects of irradiation and graft on bone remodeling differed between cortical and trabecular bone.

[1]  S. Tsui,et al.  Green fluorescent protein induces the secretion of inflammatory cytokine interleukin-6 in muscle cells. , 2007, Analytical biochemistry.

[2]  L. Volin,et al.  Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation , 2002, Bone Marrow Transplantation.

[3]  R. Cancedda,et al.  Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. , 1999, Experimental hematology.

[4]  H. Vriesendorp.  Aims of conditioning. , 2003, Experimental hematology.

[5]  S. Kaptoge,et al.  Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long‐term follow‐up of a prospective study , 2003, British journal of haematology.

[6]  A. Teti,et al.  Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. , 2006, Arthritis and rheumatism.

[7]  D. Persons,et al.  Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Butler-Browne,et al.  Adult bone marrow-derived stem cells in muscle connective tissue and satellite cell niches. , 2004, The American journal of pathology.

[9]  Yong‐Nyun Kim,et al.  C‐terminal region of Bfl‐1 induces cell death that accompanies caspase activation when fused with GFP , 2005, Journal of cellular biochemistry.

[10]  A. Neubauer,et al.  Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue , 2005, Annals of Hematology.

[11]  E. Shane,et al.  Osteoporosis after solid organ and bone marrow transplantation , 2003, Osteoporosis International.

[12]  J. Hopper,et al.  Mechanisms of Bone Loss Following Allogeneic and Autologous Hemopoietic Stem Cell Transplantation , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  R. Class,et al.  Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. Frenkel,et al.  Cells Capable of Bone Production Engraft from Whole Bone Marrow Transplants in Nonablated Mice , 1999, The Journal of experimental medicine.

[15]  A. Tabilio,et al.  Total-body irradiation in the conditioning regimens for autologous stem cell transplantation in lymphoproliferative diseases. , 1999, The oncologist.

[16]  M. Välimäki,et al.  Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  K. Sullivan,et al.  Bone Marrow Transplantation for NonMalignant Disease , 2000 .

[18]  M. Ikawa,et al.  Migration of exogenous immature hematopoietic cells into adult mouse brain parenchyma under GFP-expressing bone marrow chimera. , 1999, Biochemical and biophysical research communications.

[19]  A. Flake,et al.  High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation. , 2002, Blood.

[20]  R. Rizzoli,et al.  Allogeneic Bone Marrow Transplantation is Associated with a Preferential Femoral Neck Bone Loss , 2001, Osteoporosis International.

[21]  Won-Young Lee,et al.  Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. , 2004, The Journal of clinical endocrinology and metabolism.

[22]  K. Trott,et al.  Radiation-induced impairment of bone healing in the rat femur: effects of radiation dose, sequence and interval between surgery and irradiation. , 1998, Radiotherapy and Oncology.

[23]  A. Davis,et al.  Primitive adult hematopoietic stem cells can function as osteoblast precursors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Forestell,et al.  Mesenchymal Stem Cells as Vehicles for Gene Delivery , 2000, Clinical orthopaedics and related research.

[25]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[26]  K. Weilbaecher.  Mechanisms of osteoporosis after hematopoietic cell transplantation. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  B. Frenkel,et al.  Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. chou,et al.  Is green fluorescent protein toxic to the living cells? , 1999, Biochemical and biophysical research communications.

[29]  K. Mann,et al.  Bone Loss in Long-Term Survivors after Transplantation of Hematopoietic Stem Cells: A Prospective Study , 2000, Osteoporosis International.

[30]  Xi Jiang,et al.  Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. , 2005, Blood.

[31]  Yusuke Ueda,et al.  Induction of Senile Osteoporosis in Normal Mice by Intra‐Bone Marrow‐Bone Marrow Transplantation from Osteoporosis‐Prone Mice , 2007, Stem cells.

[32]  D. Chappard,et al.  Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies. , 2008, Micron.

[33]  W. Koo,et al.  Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. , 2001, Blood.

[34]  P. Pietschmann,et al.  Bone metabolism in patients more than five years after bone marrow transplantation , 2004, Bone Marrow Transplantation.

[35]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  D. Kwong,et al.  The effects of various irradiation doses on the growth and differentiation of marrow‐derived human mesenchymal stromal cells , 2007, Pediatric transplantation.

[37]  R. Herrmann,et al.  Pamidronate reduces bone loss after allogeneic stem cell transplantation. , 2006, The Journal of clinical endocrinology and metabolism.

[38]  M. Okabe,et al.  The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. , 2001, Journal of the American Society of Nephrology : JASN.

[39]  S. Gerson,et al.  Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) , 2002, Bone Marrow Transplantation.

[40]  U. Quast.  Whole body radiotherapy: A TBI-guideline , 2006, Journal of medical physics.

[41]  T. A. Hewett,et al.  Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. , 2001, Experimental hematology.

[42]  B. Cha,et al.  The short-term changes of bone mineral metabolism following bone marrow transplantation. , 2000, Bone.

[43]  Tomoko Nakanishi,et al.  ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.

[44]  K. Fukuda,et al.  Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. , 2005, Kidney international.

[45]  P. Bianco,et al.  Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. , 1998, The Journal of clinical investigation.

[46]  John W Hopewell,et al.  Radiation-therapy effects on bone density. , 2003, Medical and pediatric oncology.

[47]  J. Hayakawa,et al.  Generation of a Chimeric Mouse Reconstituted with Green Fluorescent Protein-Positive Bone Marrow Cells: A Useful Model for Studying the Behavior of Bone Marrow Cells in Regeneration In Vivo , 2003, International journal of hematology.